v3.26.1
Discontinued Operations
 3 Months Ended
Mar. 31, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations

Note 17. Discontinued Operations

 

On October 6, 2025, the Company entered into definitive agreements, including a bill of sale, assignment and assumption agreement providing for the transfer by the Company of certain assets, and a contract for the transfer of business share providing for the assignment by the Company of all of the Company’s right, title and interest in and to the issued and outstanding shares of Safegard Medical Kft, the Hungarian subsidiary, which is reflected in the accompanying financial statements as a discontinued operation.

 

Loss from discontinued operations for the three months ended March 31, 2025 was as follows:

 

    March 31, 2025 
OPERATING EXPENSES:      
Selling, general and administrative   $707,458 
Research and development    82,016 
Total Operating Expenses    789,474 
       
OTHER INCOME (EXPENSE):      
Foreign currency transaction loss and other    (41,295)
Other Income (Expense), net    (41,295)
       
Loss before income taxes (benefit)    (830,769)
Income tax benefit    132,000 
Net Loss from Discontinued Operations   $(698,769)

 

There were no assets or liabilities related to discontinued operations at March 31, 2026 or December 31, 2025 as the disposal occurred in October 2025.